GM
GMAB
GENMAB A/S
$24.80
-1.39%
$16.1B
No data for this timeframe.
Vol
Market Cap$16.1B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (76%)
Inst. Holders7 funds
Inst. Value$239.2M
Inst. Activity1 buys / 1 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutions — Morgan Stanley, Schwab, and UBS — significantly increased their positions in Genmab A
INST-CLUSTER — Impact 7/10
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
895,843 shares ($27.6M)
Inst.
WELLS FARGO & COMPANY/MN — DOUBLED
34,152 shares ($1.1M)
Jun 5, 2026
short_volume
Short Volume: GMAB — 64.1% short (0.5M / 0.8M)
Short: 518,971 | Exempt: 73 | TRF Vol: 809,637 | Short Ratio: 64.1% | Off-exchange volume (dark pool
Price Targets
$36.82
+46.7% upside
Strong Buy
Current $25.10
Low $32.00
Median $38.00
High $41.50
11 analysts
$32.00
$41.50
Analyst Ratings
5Strong Buy
14Buy
4Hold
1Sell
1Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Mar 27, 2026 | Wolfe Research | INITIATE | Outperform |
| Mar 2, 2026 | Wells Fargo | INITIATE | Overweight |
| Feb 23, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| Feb 18, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.30 ▼ -3.6% | $0.24 — $0.38 | -44% YoY | 5 |
| Next Q | $0.31 ▼ -8.3% | $0.26 — $0.37 | -52% YoY | 5 |
| Current FY | $1.04 ▼ -12.0% | $0.92 — $1.25 | -32% YoY | 5 |
| Next FY | $1.83 ▼ -4.1% | $1.53 — $2.08 | 76% YoY | 5 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $107.6M | — |
| MORGAN STANLEY | $56.5M | TRIM |
| FMR LLC | $32.6M | ADD |
| TWO SIGMA INVESTMENTS, LP | $27.6M | TRIM |
| BANK OF AMERICA CORP | $10.5M | TRIM |
7 institutional holders with $239.2M total value (7,765,340 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, FMR.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 3,492,850 | $107.6M | 45.0% | — |
| 2 | MORGAN STANLEY | 1,834,439 | $56.5M | 23.6% | TRIM -37.9% |
| 3 | FMR LLC | 1,057,340 | $32.6M | 13.6% | ADD +64.5% |
| 4 | TWO SIGMA INVESTMENTS, LP | 895,843 | $27.6M | 11.5% | TRIM -35.6% |
| 5 | BANK OF AMERICA CORP /DE/ | 339,917 | $10.5M | 4.4% | TRIM -42.2% |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 110,799 | $3.4M | 1.4% | ADD +32.3% |
| 7 | WELLS FARGO & COMPANY/MN | 34,152 | $1.1M | 0.4% | DOUBLED +347.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | TRIM | 1,391,215 | 895,843 | -35.6% | $27.6M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 7,625 | 34,152 | +347.9% | $1.1M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 2,697,135 | 1,674,574 | -37.9% | $51.4M | 2025-Q3 |
| FMR LLC | ADD | 680,533 | 1,119,714 | +64.5% | $34.3M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 567,795 | 328,090 | -42.2% | $10.1M | 2025-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 76,491 | 101,179 | +32.3% | $3.1M | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 484,867 | 82,170 | -83.1% | $2.5M | 2025-Q3 |
| FMR LLC | ADD | 484,846 | 680,533 | +40.4% | $14.1M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 60,948 | 76,491 | +25.5% | $1.6M | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 3,120,644 | 4,512,854 | +44.6% | $88.4M | 2025-Q1 |
| UBS Group AG | TRIM | 1,440,870 | 541,002 | -62.5% | $10.6M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 283,111 | 9,476 | -96.7% | $185.5K | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 1,318,256 | 3,120,644 | +136.7% | $65.1M | 2024-Q4 |
| MORGAN STANLEY | ADD | 1,640,390 | 2,805,881 | +71.0% | $58.6M | 2024-Q4 |
| UBS Group AG | DOUBLED | 60,448 | 1,440,870 | +2283.7% | $30.1M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 700,404 | 283,111 | -59.6% | $5.9M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 26,104 | 61,177 | +134.4% | $1.3M | 2024-Q4 |
| MORGAN STANLEY | ADD | 1,029,377 | 1,640,390 | +59.4% | $40.0M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 26,104 | — | $636.4K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (76% buy). Based on 25 analysts: 5 strong buy, 14 buy, 4 hold, 1 sell, 1 strong sell.
Analyst Price Targets
$36.82 mean target
+46.7% upside
Strong Buy (1.36)
$32.00 Low
$41.50 High
| Metric | Value |
|---|---|
| Current Price | $25.10 |
| Target Low | $32.00 |
| Target Mean | $36.82 |
| Target Median | $38.00 |
| Target High | $41.50 |
| # Analysts | 11 |
| Recommendation | Strong Buy (1.36) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.30 | $0.24 | $0.38 | -44.2% | -3.6% | 1↑ 1↓ | $7.0B | 17.3% | 5 |
| Next Q 2026-09-30 |
$0.31 | $0.26 | $0.37 | -51.8% | -8.3% | 1↑ 1↓ | $7.3B | 10.7% | 5 |
| Current FY 2026-12-31 |
$1.04 | $0.92 | $1.25 | -32.3% | -12.0% | 1↑ 1↓ | $27.6B | 17.5% | 5 |
| Next FY 2027-12-31 |
$1.83 | $1.53 | $2.08 | 75.8% | -4.1% | 0↑ 2↓ | $32.4B | 17.3% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.302 | |
| 7d ago | $0.316 | -0.013 |
| 30d ago | $0.314 | -0.011 |
| 60d ago | $0.275 | +0.027 |
| 90d ago | $0.280 | +0.022 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Mar 27, 2026 | Wolfe Research | INITIATE | — | Outperform |
| Mar 2, 2026 | Wells Fargo | INITIATE | — | Overweight |
| Feb 23, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 18, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jan 28, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 14 | 4 | 1 | 1 | 76% | |
| May 1, 2026 | 5 | 14 | 6 | 1 | 1 | 70% | |
| Apr 1, 2026 | 5 | 12 | 8 | 1 | 1 | 63% | |
| Mar 1, 2026 | 5 | 11 | 8 | 1 | 1 | 62% | |
| Feb 1, 2026 | 4 | 12 | 8 | 1 | 1 | 62% | |
| Jan 1, 2026 | 3 | 13 | 9 | 1 | 1 | 59% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 5, 2026
short_volume
Short Volume: GMAB — 64.1% short (0.5M / 0.8M)
Short: 518,971 | Exempt: 73 | TRF Vol: 809,637 | Short Ratio: 64.1% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
Clinical Trial
PRO1107 in Patients With Advanced Solid Tumors
Phase Phase 2 — TERMINATED
Jun 2, 2026
short_volume
Short Volume: GMAB — 59.9% short (0.7M / 1.2M)
Short: 693,301 | Exempt: 12,919 | TRF Vol: 1,157,757 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: GMAB — 65.5% short (0.5M / 0.7M)
Short: 461,044 | Exempt: 3,026 | TRF Vol: 703,452 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: GMAB — 58.3% short (0.3M / 0.5M)
Short: 320,089 | Exempt: 24,988 | TRF Vol: 549,249 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: GMAB — 77.2% short (0.7M / 0.9M)
Short: 674,724 | Exempt: 24,159 | TRF Vol: 874,186 | Short Ratio: 77.2% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: GMAB — 79.2% short (0.9M / 1.1M)
Short: 903,397 | Exempt: 25,655 | TRF Vol: 1,141,178 | Short Ratio: 79.2% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: GMAB — 83.4% short (0.5M / 0.6M)
Short: 466,178 | Exempt: 0 | TRF Vol: 558,733 | Short Ratio: 83.4% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: GMAB — 66.8% short (0.4M / 0.6M)
Short: 383,549 | Exempt: 6,959 | TRF Vol: 573,923 | Short Ratio: 66.8% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: GMAB — 77.1% short (0.4M / 0.6M)
Short: 441,197 | Exempt: 14,428 | TRF Vol: 572,006 | Short Ratio: 77.1% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: GMAB — 73.1% short (0.6M / 0.8M)
Short: 591,137 | Exempt: 13,503 | TRF Vol: 808,678 | Short Ratio: 73.1% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_volume
Short Volume: GMAB — 75.1% short (1.3M / 1.7M)
Short: 1,310,080 | Exempt: 76,703 | TRF Vol: 1,743,885 | Short Ratio: 75.1% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_volume
Short Volume: GMAB — 59.7% short (0.3M / 0.5M)
Short: 303,160 | Exempt: 521 | TRF Vol: 507,630 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
short_volume
Short Volume: GMAB — 84.3% short (0.6M / 0.7M)
Short: 596,437 | Exempt: 25,934 | TRF Vol: 707,451 | Short Ratio: 84.3% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
short_interest
FTD: GMAB — 51,642 shares ($1.5M) failed to deliver
Settlement: 20260413, Price: $28.25, FTD Value: $1,458,886.5, GENMAB A/S ADS (SPONSORED) (DN
Apr 10, 2026
short_volume
Short Volume: GMAB — 76.5% short (0.5M / 0.7M)
Short: 544,595 | Exempt: 1,311 | TRF Vol: 712,230 | Short Ratio: 76.5% | Off-exchange volume (dark pool + OTC)